Welcome to our dedicated page for Liqtech Internat SEC filings (Ticker: LIQT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Tracking a company that converts silicon carbide science into cleaner water and lower diesel emissions means digging into nuanced disclosures. When users ask, "Where can I find LiqTech’s quarterly earnings report 10-Q filing?" or "What do LiqTech insider trading Form 4 transactions reveal?", they are really hunting for clues about production yields, marine order pipelines, and R&D spending on next-generation membranes. Those details sit deep inside LiqTech’s SEC paperwork—often 200 pages of technical language.
Our platform delivers LiqTech SEC filings explained simply. Real-time alerts surface every LiqTech Form 4 insider transactions real-time notice, while AI-powered summaries translate legal jargon into plain English so you can understand revenue by segment, warranty provisions, or environmental risk factors within seconds. Want the LiqTech annual report 10-K simplified? Need a concise LiqTech earnings report filing analysis on gross margins? Just open the document: our AI highlights key metrics, flags forward-looking statements, and links each footnote to the exact page.
Whether you’re monitoring LiqTech executive stock transactions Form 4 before material announcements, comparing backlog disclosures across quarters, or reviewing a LiqTech proxy statement executive compensation table, Stock Titan keeps everything in one place. You’ll also see every LiqTech 8-K material events explained alongside board updates, plus historical 10-Q trend charts. Stop downloading PDFs; start understanding LiqTech SEC documents with AI, complete coverage, and updates as soon as they hit EDGAR.
LiqTech International (LIQT) filed its Q3 2025 10‑Q, showing stronger top-line performance and improved margins. Revenue rose to $3,807,274 (up 53.6% year over year), and gross margin turned positive at 19.6%, driven by pool system deliveries, aftermarket sales, and plastics, partially offset by lower DPF shipments.
The quarterly net loss narrowed to $1,459,762. For the first nine months, revenue reached $13,382,304 with gross profit improving versus last year. Cash was $7,354,024 and net working capital was $13,406,883. Total liabilities were $17,519,010 and equity $12,776,858.
The company highlighted a March 2025 amendment to its senior notes: maturity extended to May 1, 2027, and interest at 10% per annum begins January 1, 2026; related warrants were repriced to $2.00 and extended to December 31, 2029. A 90%-owned China JV received RMB 8,000,000 partner funding as a 12% loan to support marine water treatment. As of November 14, 2025, common shares outstanding were 9,627,064. Management reported disclosure controls were not effective due to ongoing material weaknesses, with remediation efforts continuing.
Insider sale by LIQT director and CEO via tax withholding The Form 4 shows Fei Chen, who serves as both a director and Chief Executive Officer of LiqTech International Inc (LIQT), had 13,021 shares of common stock withheld to satisfy tax obligations on the vesting of restricted stock units on 09/12/2025 at a price of $2.34 per share. After the withholding, Chen beneficially owned 498,593 shares. The form is signed by Fei Chen on 09/16/2025 and notes the transaction was a non-derivative disposition for tax withholding in connection with RSU vesting.
LiqTech International reported revenue of $4.96 million for the quarter (up 10.5% year-over-year) and $9.58 million for the six months (up 9.8%). Gross margins contracted to 9.8% in the quarter from 16.0% a year earlier and to 6.4% for the six months from 11.3%, driven by underutilized manufacturing after a decline in DPF sales, provisions for slow-moving inventory and development costs on a first full-scale PureFlow delivery.
The company recorded a net loss of $2.16 million for the quarter and $4.52 million for the six months, with basic and diluted loss per share of $0.22 and $0.47, respectively. Cash on hand was $8.67 million and net working capital was $14.31 million at June 30, 2025. Management states the cash balance and ongoing operations are expected to be sufficient to cover capital requirements for the next 12 months. The company formed a 90% joint venture in China that received RMB 8.0 million (~$1.1M) in R&D funding structured as a long-term loan, and disclosed material weaknesses in internal controls over financial reporting.